References
Haldorsen IS, Krossnes BK, Aarseth JH, Scheie D, Johannesen TB, Mella O, Espeland A (2007) Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989–2003: time trends in a 15-year national survey. Cancer 110(8):1803–1814. https://doi.org/10.1002/cncr.22989
Eichler AF, Batchelor TT (2006) Primary central nervous system lymphoma: presentation, diagnosis, and staging. Neurosurg Focus 21(5):E15
Okita Y, Narita Y, Miyakita Y, Ohno M, Fukushima S, Maeshima A, Kayama T, Shibui S (2012) Long-term follow-up of vanishing tumors in the brain: how should a lesion mimicking primary CNS lymphoma be managed? Clin Neurol Neurosurg 114(9):1217–1221. https://doi.org/10.1016/j.clineuro.2012.02.053
Heckmann JG, Druschky A, Kern PM (2000) “Ghost and mimicry-tumor”—primary CNS lymphoma. Nervenarzt 71(4):305–310. https://doi.org/10.1007/s001150050562
Frassanito P, Tamburrini G, Massimi L (2015) Ghost tumors of the central nervous system: definition, clinical implications, and proposal of classification. World Neurosurg 84(3):663–670. https://doi.org/10.1016/j.wneu.2015.03.063
Acknowledgements
The authors would like to thank Santorso Hospital (Santorso, Italy).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Ethical standard
The authors declare that they acted in accordance with ethical standards laid down in the 1964 Declaration of Helsinki.
Rights and permissions
About this article
Cite this article
Pistacchi, M., Gioulis, M., Sanson, F. et al. Primary central nervous system lymphoma in an immunocompetent patient: an unusual case of prolonged response to steroids. Neurol Sci 39, 941–943 (2018). https://doi.org/10.1007/s10072-017-3213-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-3213-1